• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » MedTech 100 roundup: Nearing new highs once again

MedTech 100 roundup: Nearing new highs once again

June 28, 2021 By Sean Whooley

MedTech 100 IndexHaving hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set one week prior (June 18). In all, the industry has risen 5.9% over the past three weeks.

The recent upswing shows no signs of slowing after the industry’s progress came to a halt with a -1.4% dip earlier this month. The index looks set to close in on the 114.58-point mark set in April, marking the industry’s all-time best performance.

Even with some recent setbacks, medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 22.9% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus a 82.6% increase from the mid-pandemic low of 62.13 (March 23, 2020).

The positive movement in medtech aligns with an uptick in the overall markets this past week, as the S&P 500 Index rising by 2.7% and the Dow Jones Industrial Average fared even better, increasing by 3.4%.

Medtech companies continue to rebound from the COVID-19 pandemic more than a year later. Here are some of the major highlights from the past week:

  • Smith+Nephew makes a play in remote physical therapy
  • Boston Scientific pulls trigger on Farapulse acquisition
  • Philips CPAP recall could be an opportunity for ResMed, analysts say
  • Medtronic announces first clinical procedure with its Hugo robot
  • Vicarious Surgical opens new corporate HQ in Massachusetts
  • How contract manufacturer Minnetronix decided to make its own medical device
  • Pear Therapeutics to go public via SPAC merger
  • Integra Lifesciences CEO steps down to succeed GE Healthcare CEO Murphy
  • Second Sight Medical plans to raise $50 million from public offering
  • Bigfoot Biomedical diabetes management program rolls out in some U.S. states
  • Quanta Dialysis Technologies raises $245M for portable hemodialysis system
  • Medical device startup Indago raises $10M, changes name

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Wall Street Beat Tagged With: Bigfoot Biomedical, Boston Scientific, coronavirus, COVID-19, Indago, Integra LifeSciences, Lazurite, MedTech 100 Index, Medtronic, Minnetronix Medical, Pear Therapeutics, Philips, Quanta Dialysis Technologies, Second Sight, Smith+Nephew, Vicarious Surgical

More recent news

  • Endologix is now Rhevera Medical
  • iRhythm completes acquisition of VitalConnect
  • Medtronic taps Siemens Healthineers exec as new Cardiac Ablations Solutions VP
  • Stryker will have a new CEO next year
  • Zenflow nets $52M, Cook Medical deal for in-office enlarged prostate implant

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy